DK0720597T3 - Triarylethylenderivater til terapeutisk anvendelse - Google Patents
Triarylethylenderivater til terapeutisk anvendelseInfo
- Publication number
- DK0720597T3 DK0720597T3 DK94927182T DK94927182T DK0720597T3 DK 0720597 T3 DK0720597 T3 DK 0720597T3 DK 94927182 T DK94927182 T DK 94927182T DK 94927182 T DK94927182 T DK 94927182T DK 0720597 T3 DK0720597 T3 DK 0720597T3
- Authority
- DK
- Denmark
- Prior art keywords
- therapeutic use
- derivatives
- triarylethylene
- agents
- triarylethylene derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/20—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12661493A | 1993-09-24 | 1993-09-24 | |
| US08/259,797 US5525633A (en) | 1993-09-24 | 1994-06-15 | Triaryl-ethylene derivatives |
| PCT/US1994/009314 WO1995008528A1 (en) | 1993-09-24 | 1994-08-19 | Triaryl-ethylene derivatives for use in therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0720597T3 true DK0720597T3 (da) | 1998-10-07 |
Family
ID=26824862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94927182T DK0720597T3 (da) | 1993-09-24 | 1994-08-19 | Triarylethylenderivater til terapeutisk anvendelse |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5684004A (da) |
| EP (1) | EP0720597B1 (da) |
| JP (1) | JPH09503761A (da) |
| CN (1) | CN1131415A (da) |
| AT (1) | ATE165594T1 (da) |
| AU (1) | AU678535B2 (da) |
| CA (1) | CA2171728C (da) |
| DE (1) | DE69409961T2 (da) |
| DK (1) | DK0720597T3 (da) |
| ES (1) | ES2115975T3 (da) |
| FI (1) | FI961339A (da) |
| HU (1) | HUT75933A (da) |
| IL (1) | IL111018A0 (da) |
| NO (1) | NO306292B1 (da) |
| NZ (1) | NZ273433A (da) |
| PL (1) | PL177833B1 (da) |
| WO (1) | WO1995008528A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002322720B2 (en) | 2001-07-25 | 2008-11-13 | Raptor Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
| PL1889198T3 (pl) | 2005-04-28 | 2015-04-30 | Proteus Digital Health Inc | System farmakologiczno-informatyczny |
| WO2008036682A2 (en) | 2006-09-18 | 2008-03-27 | Raptor Pharmaceutical Inc. | Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates |
| ES2919563T3 (es) | 2009-02-20 | 2022-07-27 | Enhanx Biopharm Inc | Sistema de administración de medicamentos a base de glutatión |
| JP2012526144A (ja) | 2009-05-06 | 2012-10-25 | ラボラトリー スキン ケア インコーポレイテッド | 活性物質−リン酸カルシウム粒子複合体を含む経皮送達組成物およびその使用方法 |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1099093A (en) * | 1965-09-03 | 1968-01-17 | Ici Ltd | Alkene derivatives |
| EP0002097B1 (en) * | 1977-08-22 | 1981-08-05 | Imperial Chemical Industries Plc | Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them |
-
1994
- 1994-08-19 EP EP94927182A patent/EP0720597B1/en not_active Expired - Lifetime
- 1994-08-19 AT AT94927182T patent/ATE165594T1/de not_active IP Right Cessation
- 1994-08-19 PL PL94313594A patent/PL177833B1/pl unknown
- 1994-08-19 AU AU76707/94A patent/AU678535B2/en not_active Ceased
- 1994-08-19 ES ES94927182T patent/ES2115975T3/es not_active Expired - Lifetime
- 1994-08-19 DE DE69409961T patent/DE69409961T2/de not_active Expired - Fee Related
- 1994-08-19 WO PCT/US1994/009314 patent/WO1995008528A1/en active IP Right Grant
- 1994-08-19 DK DK94927182T patent/DK0720597T3/da active
- 1994-08-19 CA CA002171728A patent/CA2171728C/en not_active Expired - Fee Related
- 1994-08-19 HU HU9600727A patent/HUT75933A/hu unknown
- 1994-08-19 CN CN94193479A patent/CN1131415A/zh active Pending
- 1994-08-19 JP JP7509757A patent/JPH09503761A/ja not_active Ceased
- 1994-08-19 NZ NZ273433A patent/NZ273433A/en unknown
- 1994-09-21 IL IL11101894A patent/IL111018A0/xx unknown
-
1995
- 1995-06-05 US US08/463,792 patent/US5684004A/en not_active Expired - Fee Related
-
1996
- 1996-03-22 FI FI961339A patent/FI961339A/fi not_active IP Right Cessation
- 1996-03-25 NO NO961204A patent/NO306292B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2171728A1 (en) | 1995-03-30 |
| CN1131415A (zh) | 1996-09-18 |
| HU9600727D0 (en) | 1996-05-28 |
| US5684004A (en) | 1997-11-04 |
| DE69409961T2 (de) | 1998-09-10 |
| ATE165594T1 (de) | 1998-05-15 |
| FI961339A0 (fi) | 1996-03-22 |
| ES2115975T3 (es) | 1998-07-01 |
| HUT75933A (en) | 1997-05-28 |
| IL111018A0 (en) | 1994-11-28 |
| AU678535B2 (en) | 1997-05-29 |
| NZ273433A (en) | 1997-11-24 |
| FI961339A (fi) | 1996-03-22 |
| NO306292B1 (no) | 1999-10-18 |
| PL313594A1 (en) | 1996-07-08 |
| DE69409961D1 (de) | 1998-06-04 |
| JPH09503761A (ja) | 1997-04-15 |
| AU7670794A (en) | 1995-04-10 |
| PL177833B1 (pl) | 2000-01-31 |
| NO961204D0 (no) | 1996-03-25 |
| NO961204L (no) | 1996-03-25 |
| CA2171728C (en) | 2001-11-13 |
| EP0720597B1 (en) | 1998-04-29 |
| EP0720597A1 (en) | 1996-07-10 |
| WO1995008528A1 (en) | 1995-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| ID23374A (id) | Halogenopirimidin | |
| NO990405L (no) | Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som antidiabetiske midler | |
| ES2184149T3 (es) | Paclitaxeles 6-tio sustituidos. | |
| MY104685A (en) | Substituted thiazoles and their use as fungicides. | |
| ATE148130T1 (de) | Typ-iv-dipeptidyl-aminopeptidase-inhibitoren | |
| TR200200068T2 (tr) | Nematisital triflüorobütenler | |
| PT1017659E (pt) | Tetra-hidronaftalenos substituidos e compostos analogos | |
| ATE167670T1 (de) | N-alkylthiopolyaminderivate als radioprotektive mittel | |
| BR9711586A (pt) | Compostos e uso dos mesmo | |
| EA199900362A1 (ru) | Новые соединения, полезные для использования в качестве нейрозащитных средств | |
| ATE203519T1 (de) | Chinolinderivate als antimalariamittel | |
| FI951511A0 (fi) | IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon | |
| MX9101958A (es) | Inhibidores de acat de urea de aminosulfonilo | |
| MY105128A (en) | Bu-3608 derivatives. | |
| DK0720597T3 (da) | Triarylethylenderivater til terapeutisk anvendelse | |
| ES2152315T3 (es) | Xamoneline tartrato. | |
| ATE68486T1 (de) | 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl - 1h-imidazol. | |
| BR9611904A (pt) | Dioxidos de ditiazol | |
| FI945414A (fi) | Menetelmä N,N-disubstituoidun aminofenolin valmistamiseksi | |
| UA16247A1 (uk) | N-(3-ХЛОРО-1,4-HАФТОХІHОHІЛ-2)-2-Д, alРha-АСПАРАГІHОВУ КИСЛОТА, ЩО ПРОЯВЛЯЄ КАРДІОСТИМУЛЮЮЧІ ВЛАСТИВОСТІ |